Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

17.36
Delayed Data
As of Dec 11
 -0.46 / -2.58%
Today’s Change
4.72
Today|||52-Week Range
21.35
+210.00%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close17.82
Today’s open18.30
Day’s range16.50 - 18.53
Volume585,413
Average volume (3 months)585,918
Market cap$548.9M
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+18.45%
Earnings growth (this year)-2.40%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+140.14%
P/E ratioNM
Price/Sales5.59
Price/Book7.07

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...0.000.00%
XBITXBiotech Inc-0.19-4.08%
ASTAsterias Biotherapeu...+0.05+2.50%
COOLPolarityte Inc-2.06-7.28%
Data as of 8:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$25.1M
Annual profit (last year)-$73.4M
Net profit margin-292.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Scott T. McMillan
Corporate headquarters
Amsterdam, Noord-holland

Forecasts